Rein Therapeutics (NASDAQ:RNTX) stock is trading higher on Monday, with a session volume of 41.2 million compared to its average volume of 162.67 thousand, according to data from Benzinga Pro.What Happened: The U.S. Food and Drug Administration (FDA) on Monday lifted the full clinical hold on the company’s Phase 2 RENEW trial of LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).The FDA’s decision follows a review of Rein’s submission, which addressed all of the agency’s concerns.The agency confirm ...